Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

NCT04433572 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Artery Disease
Critical Limb Ischemia

Interventions

DRUG: Temsirolimus
DRUG: Saline placebo

Sponsor

Mercator MedSystems, Inc.